#arrowhead pharmaceuticals

1 story

#arwr #biotechnology stocks #genetic medicines #investor sentiment #market decline #rna interference therapeutics #sector selloff

Arrowhead Pharma drops 5.4% in biotech selloff
Arrowhead Pharmaceuticals fell alongside five peer companies in a coordinated sector decline with no company-specific catalyst.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m